Alexa Núñez

740 total citations
40 papers, 375 citations indexed

About

Alexa Núñez is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Alexa Núñez has authored 40 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 9 papers in Oncology. Recurrent topics in Alexa Núñez's work include Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Asthma and respiratory diseases (11 papers) and Protease and Inhibitor Mechanisms (8 papers). Alexa Núñez is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Asthma and respiratory diseases (11 papers) and Protease and Inhibitor Mechanisms (8 papers). Alexa Núñez collaborates with scholars based in Spain, Italy and United Kingdom. Alexa Núñez's co-authors include Marc Miravitlles, Míriam Barrecheguren, Cristina Esquinas, Mónica Monteagudo, Jibril Mohammed, Gerard Urrútia, Esther Rodríguez, Evgeni Mekov, Pietro Pirina and Francisco Rodríguez‐Frias and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Quality of Life Research.

In The Last Decade

Alexa Núñez

35 papers receiving 366 citations

Peers

Alexa Núñez
Sally Worsley United Kingdom
Sreeram V Ramagopalan United Kingdom
Juliet Hockenhull United Kingdom
S. Zonato Italy
N.J.J. Schlösser Netherlands
Gurpreet Kaur United States
Sally Worsley United Kingdom
Alexa Núñez
Citations per year, relative to Alexa Núñez Alexa Núñez (= 1×) peers Sally Worsley

Countries citing papers authored by Alexa Núñez

Since Specialization
Citations

This map shows the geographic impact of Alexa Núñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexa Núñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexa Núñez more than expected).

Fields of papers citing papers by Alexa Núñez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexa Núñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexa Núñez. The network helps show where Alexa Núñez may publish in the future.

Co-authorship network of co-authors of Alexa Núñez

This figure shows the co-authorship network connecting the top 25 collaborators of Alexa Núñez. A scholar is included among the top collaborators of Alexa Núñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexa Núñez. Alexa Núñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Núñez, Alexa, Cristina Esquinas, Hanan Tanash, et al.. (2025). Routine Blood Biomarkers and Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency from the EARCO Registry. Respiration. 105(3). 370–380.
2.
Rodríguez‐Frias, Francisco, Pascual Medina, Roser Ferrer, et al.. (2025). Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency. PLoS ONE. 20(6). e0324237–e0324237.
3.
Barrecheguren, Míriam, et al.. (2024). Motivation and Confidence about Physical Activity in Chronic Obstructive Pulmonary Disease Patients: Health Benefits Matter to Patients. Respiration. 103(7). 378–387. 1 indexed citations
4.
Torrego-Ellacuría, Macarena, Manuel Fuentes, Vicente Martín, et al.. (2023). Clinical and economic impact of COVID-19 on people with obesity in a Spanish cohort during the first pandemic peak. Frontiers in Endocrinology. 14. 1146517–1146517. 1 indexed citations
5.
Núñez, Alexa, Cristina Esquinas, Francisco Rodríguez‐Frias, et al.. (2023). Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia. Respiratory Medicine. 218. 107394–107394. 1 indexed citations
6.
Martínez‐García, Miguel Ángel, David Rigau, Míriam Barrecheguren, et al.. (2022). Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 14 indexed citations
7.
Barrecheguren, Míriam, Mónica Monteagudo, Marc Miravitlles, et al.. (2022). Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain. npj Primary Care Respiratory Medicine. 32(1). 11–11. 3 indexed citations
8.
Monteagudo, Mónica, Alexa Núñez, Míriam Barrecheguren, & Marc Miravitlles. (2022). Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study. Archivos de Bronconeumología. 58(10). 699–707. 2 indexed citations
9.
González, Ángel, Alexa Núñez, Míriam Barrecheguren, et al.. (2022). New variants of alpha-1-antitrypsin: structural simulations and clinical expression. Respiratory Research. 23(1). 339–339. 6 indexed citations
10.
Miravitlles, Marc, et al.. (2021). Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review. 30(160). 210075–210075. 72 indexed citations
11.
Núñez, Alexa, Evgeni Mekov, Cristina Esquinas, et al.. (2020). Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease. SHILAP Revista de lepidopterología.
12.
Núñez, Alexa, Míriam Barrecheguren, Cristina Esquinas, et al.. (2020). <p>Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory</p>. International Journal of COPD. Volume 15. 2421–2431. 4 indexed citations
13.
Núñez, Alexa, Evgeni Mekov, Silvia Negri, et al.. (2020). Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers. Respiratory Medicine. 171. 106091–106091. 3 indexed citations
14.
Núñez, Alexa, Evgeni Mekov, Cristina Esquinas, et al.. (2020). <p>Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease</p>. International Journal of COPD. Volume 15. 681–690. 24 indexed citations
15.
Bellemare, Judith, Nathalie Gaudreault, Alexa Núñez, et al.. (2020). The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém). Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 8(1). 31–40. 1 indexed citations
16.
Esquinas, Cristina, María Antonia Ramón, Alexa Núñez, et al.. (2019). Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Quality of Life Research. 29(3). 607–617. 17 indexed citations
17.
Esquinas, Cristina, Míriam Barrecheguren, Esther Rodríguez, et al.. (2018). Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT). International Journal of COPD. Volume 13. 1001–1007. 19 indexed citations
18.
Núñez, Alexa, et al.. (2018). Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire. International Journal of COPD. Volume 13. 3837–3844. 3 indexed citations
19.
Esquinas, Cristina, Sabina Janciauskiene, Beata Olejnicka, et al.. (2017). Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency. International Journal of COPD. Volume 12. 3381–3390. 21 indexed citations
20.
Bayés, Beatriu, Ricardo Lauzurica, M.C. Pastor, et al.. (2009). Effect of Low Doses of Atorvastatin on the Urinary Peptide Profile of Kidney Transplant Patients. Transplantation Proceedings. 41(6). 2111–2114. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026